MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)
Clinical trial NCT00532935 · COMPLETED
Trial details
- NCT number
- NCT00532935
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-26
- Primary completion
- 2009-10-23
- Enrollment
- 517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.